Elective and emergency caesarean section in population controls and patient groups expressed as proportions and risk differences
Total | Elective CS | % | Risk difference (95% CI) | P value* | |
Population controls | 575 763 | 32 114 | 5.6 | ||
axSpA, total | 312 | 31 | 9.4 | 4.4 (1.5 to 8.2) | 0.001 |
Active axSpA† | 114 | 15 | 13.2 | 7.6 (2.6 to 15.0) | <0.001 |
Inactive axSpA† | 131 | 11 | 8.4 | 2.8 (−0.8 to 8.8) | 0.22 |
PsA, total | 121 | 12 | 9.9 | 4.3 (0.2 to 11.0) | 0.060 |
Active PsA† | 27 | 2 | 7.4 | 1.8 (−3.5 to 17.8) | 0.66‡ |
Inactive PsA† | 64 | 7 | 10.9 | 5.4 (−0.2 to 15.3) | 0.091‡ |
Total | Emergency CS | % | Risk difference (95% CI) | P value* | |
Population controls | 575 763 | 57 691 | 10.0 | ||
axSpA, total | 312 | 39 | 12.5 | 2.5 (−0.7 to 6.6) | 0.17 |
Active axSpA† | 114 | 12 | 10.5 | 0.5 (−3.9 to 7.5) | 0.98 |
Inactive axSpA† | 131 | 13 | 9.9 | 0.1 (−4.1 to 6.2) | 1.0 |
PsA, total | 121 | 25 | 20.7 | 10.6 (4.4 to 18.7) | <0.001 |
Active PsA† | 27 | 7 | 25.9 | 15.9 (3.2 to 34.7) | 0.015‡ |
Inactive PsA† | 64 | 13 | 20.3 | 10.3 (2.3 to 21.7) | 0.011 |
p-values in bold are statistically significant values
*P value for patient group compared with population controls.
†In third trimester.
‡Fisher’s exact test.
axSpA, axial spondyloarthritis; CS, caesarean section; PsA, psoriatic arthritis.